The forecasted data indicates a consistent decline in the US government budget appropriations or outlays for R&D in health from 2024 to 2028, starting at 62.11 billion USD PPP and decreasing to 53.82 billion USD PPP. This downward trend reflects a year-on-year decrease, with the total compounded annual growth rate (CAGR) over the 5-year period pointing to an average annual reduction in funds. As of 2023, the budget stood at 63.5 billion USD PPP, showing a marked downtrend.
Future trends to watch for include potential policy shifts that may alter these projections, economic conditions that could influence budget allocations, and emerging health crises that may shift governmental priorities. These factors will be crucial in determining whether the downward trajectory continues or stabilizes.
